Fish Vaccine Market

Fish Vaccine Market Size (2023 to 2024)

The Fish Vaccine Market Size is valued at USD 402.47 Million in 2023 and is anticipated to reach USD 646.35 Million by 2029 with a CAGR of 7.2% during the forecast period.

Fish vaccination is the process where the fish is vaccinated to induce defence mechanisms against pathogen. Fish vaccines are immunized in the same way we immunize other animals. Fish is immunized by injection, intramuscular or intraperitoneal or by oral where the vaccine are mixed with feed. Fishes respond to the vaccine where the response depends on the water temperature. Higher the temperature of the water, faster the immune response of the fish to the vaccine. Fish vaccines help in reducing the antibiotics where these are effective in reducing the specific disease related issues. Fish vaccines are advantageous compared to the antibiotics as they are derived natural materials which does not leave any residue of the product.

MARKET DRIVERS:

The growing aquaculture production and high prevalence of the infectious diseases in the aquaculture are primarily driving the fish vaccine market growth. Increasing demand for the fish-derived food across the globe due to nutritious health benefits of the fish. According to Aquaculture Research and Development Journal approximately 219 cases of infectious diseases in the fresh aquaculture are registered in a gap of 4 years. Among these 74.86% are parasitic, 12.8% are bacterial, and 1.8% are viral and other cases are mix of parasitic and bacterial diseases. The high prevalence of these infectious diseases among the aquaculture is expected to propel the growth of demand for the fish vaccines hence, fueling the market revenue. The advantages of the fish vaccine compared to the antibiotics is major reason which is adding fuel to the market expansion across the globe. Vaccines are expected to provide longer prophylactic effect and healthier fish with reduction in the use of high doses of antibiotics.

The growing technological advancements in the veterinary healthcare is expected to propel the market expansion. Development of novel vaccines which are advantageous in the administration with efficient results are enhancing the adoption of fish vaccines over the antibiotics which is rising the market value. By using the advanced technologies in the bioinformatics tools and immunoproteomics, genomics, the researchers are focusing on working to identify the potential targeted epitopes which can be recognized by the immune cells which gives effective immune response to the pathogens. All these factors are bolstering the adoption of fish vaccine and rising the market value.

The expanding business by the market players by investing in the research and development activities to induce better immune responses by the fish by administrating vaccines. Researchers are focusing on developing innovative vaccinations with low adverse reactions. These investments in the innovations are expected to provide growth opportunities for the market growth during the forecast period. There is growing demand for the eco-friendly vaccines which are effective and does not harm the environment. The rising demand for the fish products is expected to augment the market growth over the forecast period. The growing government initiatives for promoting the benefits of fish vaccines and the rising collaborations, acquisitions by the market players are expected to drive the market growth over the forecast period.

MARKET RESTRAINTS:

The cost of fish vaccines is high which is expected to witness difficulties for the aquaculture farmers from the low economic regions. The expensiveness of the vaccines is expected to limit the market growth due to affordability and accessibility for fish farmers. Another restraining factor for the market growth is lack of awareness among the fish farmers. Most of the uneducated farmers are less aware of the benefits produced by the fish vaccines. Additionally, the farmers may not have required knowledge and skills regarding the administration of vaccine to the fish which may impede the market growth due to low adoption rates. Few vaccines have limited efficacy towards certain infectious disease which reduce the effectiveness and hamper the adoption of fish vaccines among farmers.

The regulatory approvals are challenging for the market expansion as certain nations have stringent regulations regarding the fish vaccines and approvals. The approval of the fish vaccines is time-consuming and complex which is expected to limit the count of available vaccines into the market. Another challenging factor is no availability of customized vaccines for all the species, diseases. The limited efficacy of the vaccines against certain diseases is limiting the adoption rate by impacting on the market growth.

COVID-19 Impact on Fish Vaccine Market:

The Pandemic had impacted various businesses across the globe due to lockdown regulations which disrupted the supply chain of the healthcare industry. Due to lockdown the production and manufacturing units were shutdown making delays in the distribution. According to study published in ScienceDirect in 2021, the aquaculture and fisheries sector mainly in the developing countries had severely affected by the COVID-19. The pandemic had also positive impact on the fisheries as due to lockdown there is low disturbance in the fishing activities. Due to the disruptions in the transportation, the costs had increased which included maintenance costs.

REPORT COVERAGE:

This research report on the global fish vaccine market has been segmented and sub-segmented based on Type, Route of Administration, Application, Species, and region.

Fish Vaccine Market - By Type:

• Inactivated Vaccine
• Attenuated Vaccine
• Toxoid Vaccine
• Killed Vaccine
• Recombinant Vaccine

The inactivated vaccines segment held the largest share in the global market revenue in 2023. As the inactivated vaccines are maintaining the immunogenicity and leading to specific resistance in the animals. Physical inactivation techniques include use of ultraviolet light, high-temperature heating, ultrasound, and gamma rays. The chemical inactivation uses the chemicals to breakdown the nucleic acids and proteins of the bacteria. The inactivated vaccines have various advantages as they are easy to prepare, store, and transport as well as high level of safety and stability.

The recombinant vaccines are expected to have rapid growth over the forecast period. Researchers are focusing on developing recombinant vaccines which teaches the immune system how to fight against the diseases. Recombinant vaccines are novel and effective than the DNA vaccines.

Fish Vaccine Market - By Route of Administration

• Injection
• Immersion
• Oral
• Spray

The injection segment dominated the global market with largest market share in 2023. Injection vaccines are better method for producing antibody response in the fish. Most of the aquaculture vaccines are administered by injections to fight against the bacteria. Injection route of administration is through intramuscular or intraperitoneal.

The immersion segment is projected to register significant growth during the forecast period. In this method small portion of medicated water is prepared and then the fish is immersed in the water for short period and then returned to the normal place. This method is simple and efficient which is beneficial and fueling the market growth over the forecast period.

Fish Vaccine Market - By Application:

• Bacterial
• Viral
• Parasitic

The bacterial segment held the largest share in the global market and is expected to register significant CAGR during the forecast period. Due to poor water quality, dumping waste in the water, improper handling, and significant changes in the temperature, mostly cause bacterial infections in the fish which is estimated to drive the market growth of vaccines. The parasitic and viral segments are gaining traction due to rising prevalence of parasitic infectious diseases across the aquaculture.

Fish Vaccine Market - By Species:

• Salmon
• Trout
• Tilapia
• Others

The salmon segment dominated the global market with largest market value in 2023 and is expected to maintain the domination during the forecast period. The salmon species are high prone to the infectious diseases which is demanding the requirement of vaccines. The Tilapia segment is projected to have significant growth over the forecast period.

Fish Vaccine Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

The North American segment dominated the global market in 2023 with largest share. The North American region consists of advanced healthcare system across the world. The developed countries like US and Canada are holding top position in the advanced healthcare technology including veterinary and presence of key market players are driving market growth of fish vaccines in the region. Increasing demand for the sea food and fish products is demanding the need of preventing and controlling the diseases among fish. Presence of large number of fish farms with aquaculture facilities in the region is adding fuel to the market expansion.

The Asia Pacific region is projected to have rapid growth over the forecast period due to rising demand of sea food across the countries like China, India and Japan. The Asia Pacific region is home to largest aquaculture facilities. Rising R&D activities and the new product launches are boosting the growth of market value.

KEY MARKET PLAYERS:

Zoetis, Merck & Co., Inc., HIPRA, Anicon Labor GmbH, Tecnovax, Veterquimica, Aqua Vet, Indian Immunologicals,Elanco Animal Health Inc, Benchmark Animal Health

RECENT MARKET DEVELOPMENTS:

• In March 2023, Indian Immunologicals Limited partnered with India Council of Agricultural Research (ICAR) for development of vaccine against hemorrhagic septicemia in the freshwater fish.
• In January 2023, the European Commision funded USD7.88 Million to PerformFISH project for exploring and detecting the major causes of stagnancy in the Mediterranean aquaculture.
• In December 2022, Cochin University of Science and Technology awarded the international aquatic vaccine development project which is in collaboration with Modern Research Institute and Nord University.
• In January 2022, Benchmark Animal Health, leading biotechnology company and Cerma group, world famous salmon farming company had stated that they received funding from Norweigan Research Council for supporting the development of vaccine against Tenacibaculum.
• In February 2021, the Foundation of Food & Agriculture Research funded huge amount to create delivery system for vaccine which helps in stopping the tilapia lake virus and other diseases in the aquaculture.